The Experts below are selected from a list of 2283 Experts worldwide ranked by ideXlab platform
Bryan Boulanger - One of the best experts on this subject based on the ideXlab platform.
-
concentrations and mass loadings of hormones alkylphenols and alkylphenol ethoxylates in healthcare Facility wastewaters
Chemosphere, 2010Co-Authors: Pranav M. Nagarnaik, Marc A Mills, Bryan BoulangerAbstract:Abstract Healthcare Facility wastewaters are an anticipated source of known endocrine disrupting chemicals to the environment. In this study, the composition and magnitude of eight steroid hormones, octylphenol (OP), nonylphenol (NP), 16 nonylphenol ethoxylates (NPEOs), and 10 octylphenol ethoxylates (OPEOs) in wastewater from a(n) hospital, nursing Facility, Assisted Living Facility, and independent Living Facility are presented. Steroid hormone concentrations were variable for each sampling location, ranging from a non-detectable concentration of 17β-ethynylestradiol in all samples to 127 ng L −1 androstenedione in the hospital’s wastewater composite. OP and NP were not detected in any site’s samples. However, NPEOs were found at each sampling location with a maximum combined concentration of 260 μg L −1 for NPEOs with a chain length between 3 and 18 units in the Assisted Living Facility composite sample. OPEOs were only found in the hospital and nursing facilities samples with a maximum combined OPEO concentration of 13 μg L −1 for OPEOs with a chain length between 2 and 12 units in hospital wastewater. The total mass loading of hormones to the municipal sewer system from each Facility ranged from 2.5 mg d –1 at the Assisted Living Facility to 138 mg d –1 at the hospital. The total mass loading of the alklyphenol ethoxylates (NPEO + OPEO) is considerably higher than the estimated hormone mass loadings, ranging from 1.8 g d –1 at the independent Living Facility to 54 g d –1 at the hospital Facility.
-
concentrations and mass loadings of hormones alkylphenols and alkylphenol ethoxylates in healthcare Facility wastewaters
Chemosphere, 2010Co-Authors: Pranav M. Nagarnaik, Marc A Mills, Bryan BoulangerAbstract:Healthcare Facility wastewaters are an anticipated source of known endocrine disrupting chemicals to the environment. In this study, the composition and magnitude of eight steroid hormones, octylphenol (OP), nonylphenol (NP), 16 nonylphenol ethoxylates (NPEOs), and 10 octylphenol ethoxylates (OPEOs) in wastewater from a(n) hospital, nursing Facility, Assisted Living Facility, and independent Living Facility are presented. Steroid hormone concentrations were variable for each sampling location, ranging from a non-detectable concentration of 17beta-ethynylestradiol in all samples to 127ngL(-1) androstenedione in the hospital's wastewater composite. OP and NP were not detected in any site's samples. However, NPEOs were found at each sampling location with a maximum combined concentration of 260microgL(-1) for NPEOs with a chain length between 3 and 18 units in the Assisted Living Facility composite sample. OPEOs were only found in the hospital and nursing facilities samples with a maximum combined OPEO concentration of 13microgL(-1) for OPEOs with a chain length between 2 and 12 units in hospital wastewater. The total mass loading of hormones to the municipal sewer system from each Facility ranged from 2.5mgd(-1) at the Assisted Living Facility to 138mgd(-1) at the hospital. The total mass loading of the alklyphenol ethoxylates (NPEO+OPEO) is considerably higher than the estimated hormone mass loadings, ranging from 1.8gd(-1) at the independent Living Facility to 54gd(-1) at the hospital Facility.
Pranav M. Nagarnaik - One of the best experts on this subject based on the ideXlab platform.
-
concentrations and mass loadings of hormones alkylphenols and alkylphenol ethoxylates in healthcare Facility wastewaters
Chemosphere, 2010Co-Authors: Pranav M. Nagarnaik, Marc A Mills, Bryan BoulangerAbstract:Abstract Healthcare Facility wastewaters are an anticipated source of known endocrine disrupting chemicals to the environment. In this study, the composition and magnitude of eight steroid hormones, octylphenol (OP), nonylphenol (NP), 16 nonylphenol ethoxylates (NPEOs), and 10 octylphenol ethoxylates (OPEOs) in wastewater from a(n) hospital, nursing Facility, Assisted Living Facility, and independent Living Facility are presented. Steroid hormone concentrations were variable for each sampling location, ranging from a non-detectable concentration of 17β-ethynylestradiol in all samples to 127 ng L −1 androstenedione in the hospital’s wastewater composite. OP and NP were not detected in any site’s samples. However, NPEOs were found at each sampling location with a maximum combined concentration of 260 μg L −1 for NPEOs with a chain length between 3 and 18 units in the Assisted Living Facility composite sample. OPEOs were only found in the hospital and nursing facilities samples with a maximum combined OPEO concentration of 13 μg L −1 for OPEOs with a chain length between 2 and 12 units in hospital wastewater. The total mass loading of hormones to the municipal sewer system from each Facility ranged from 2.5 mg d –1 at the Assisted Living Facility to 138 mg d –1 at the hospital. The total mass loading of the alklyphenol ethoxylates (NPEO + OPEO) is considerably higher than the estimated hormone mass loadings, ranging from 1.8 g d –1 at the independent Living Facility to 54 g d –1 at the hospital Facility.
-
concentrations and mass loadings of hormones alkylphenols and alkylphenol ethoxylates in healthcare Facility wastewaters
Chemosphere, 2010Co-Authors: Pranav M. Nagarnaik, Marc A Mills, Bryan BoulangerAbstract:Healthcare Facility wastewaters are an anticipated source of known endocrine disrupting chemicals to the environment. In this study, the composition and magnitude of eight steroid hormones, octylphenol (OP), nonylphenol (NP), 16 nonylphenol ethoxylates (NPEOs), and 10 octylphenol ethoxylates (OPEOs) in wastewater from a(n) hospital, nursing Facility, Assisted Living Facility, and independent Living Facility are presented. Steroid hormone concentrations were variable for each sampling location, ranging from a non-detectable concentration of 17beta-ethynylestradiol in all samples to 127ngL(-1) androstenedione in the hospital's wastewater composite. OP and NP were not detected in any site's samples. However, NPEOs were found at each sampling location with a maximum combined concentration of 260microgL(-1) for NPEOs with a chain length between 3 and 18 units in the Assisted Living Facility composite sample. OPEOs were only found in the hospital and nursing facilities samples with a maximum combined OPEO concentration of 13microgL(-1) for OPEOs with a chain length between 2 and 12 units in hospital wastewater. The total mass loading of hormones to the municipal sewer system from each Facility ranged from 2.5mgd(-1) at the Assisted Living Facility to 138mgd(-1) at the hospital. The total mass loading of the alklyphenol ethoxylates (NPEO+OPEO) is considerably higher than the estimated hormone mass loadings, ranging from 1.8gd(-1) at the independent Living Facility to 54gd(-1) at the hospital Facility.
Marc A Mills - One of the best experts on this subject based on the ideXlab platform.
-
concentrations and mass loadings of hormones alkylphenols and alkylphenol ethoxylates in healthcare Facility wastewaters
Chemosphere, 2010Co-Authors: Pranav M. Nagarnaik, Marc A Mills, Bryan BoulangerAbstract:Abstract Healthcare Facility wastewaters are an anticipated source of known endocrine disrupting chemicals to the environment. In this study, the composition and magnitude of eight steroid hormones, octylphenol (OP), nonylphenol (NP), 16 nonylphenol ethoxylates (NPEOs), and 10 octylphenol ethoxylates (OPEOs) in wastewater from a(n) hospital, nursing Facility, Assisted Living Facility, and independent Living Facility are presented. Steroid hormone concentrations were variable for each sampling location, ranging from a non-detectable concentration of 17β-ethynylestradiol in all samples to 127 ng L −1 androstenedione in the hospital’s wastewater composite. OP and NP were not detected in any site’s samples. However, NPEOs were found at each sampling location with a maximum combined concentration of 260 μg L −1 for NPEOs with a chain length between 3 and 18 units in the Assisted Living Facility composite sample. OPEOs were only found in the hospital and nursing facilities samples with a maximum combined OPEO concentration of 13 μg L −1 for OPEOs with a chain length between 2 and 12 units in hospital wastewater. The total mass loading of hormones to the municipal sewer system from each Facility ranged from 2.5 mg d –1 at the Assisted Living Facility to 138 mg d –1 at the hospital. The total mass loading of the alklyphenol ethoxylates (NPEO + OPEO) is considerably higher than the estimated hormone mass loadings, ranging from 1.8 g d –1 at the independent Living Facility to 54 g d –1 at the hospital Facility.
-
concentrations and mass loadings of hormones alkylphenols and alkylphenol ethoxylates in healthcare Facility wastewaters
Chemosphere, 2010Co-Authors: Pranav M. Nagarnaik, Marc A Mills, Bryan BoulangerAbstract:Healthcare Facility wastewaters are an anticipated source of known endocrine disrupting chemicals to the environment. In this study, the composition and magnitude of eight steroid hormones, octylphenol (OP), nonylphenol (NP), 16 nonylphenol ethoxylates (NPEOs), and 10 octylphenol ethoxylates (OPEOs) in wastewater from a(n) hospital, nursing Facility, Assisted Living Facility, and independent Living Facility are presented. Steroid hormone concentrations were variable for each sampling location, ranging from a non-detectable concentration of 17beta-ethynylestradiol in all samples to 127ngL(-1) androstenedione in the hospital's wastewater composite. OP and NP were not detected in any site's samples. However, NPEOs were found at each sampling location with a maximum combined concentration of 260microgL(-1) for NPEOs with a chain length between 3 and 18 units in the Assisted Living Facility composite sample. OPEOs were only found in the hospital and nursing facilities samples with a maximum combined OPEO concentration of 13microgL(-1) for OPEOs with a chain length between 2 and 12 units in hospital wastewater. The total mass loading of hormones to the municipal sewer system from each Facility ranged from 2.5mgd(-1) at the Assisted Living Facility to 138mgd(-1) at the hospital. The total mass loading of the alklyphenol ethoxylates (NPEO+OPEO) is considerably higher than the estimated hormone mass loadings, ranging from 1.8gd(-1) at the independent Living Facility to 54gd(-1) at the hospital Facility.
David Casarett - One of the best experts on this subject based on the ideXlab platform.
-
hospice care in Assisted Living facilities versus at home results of a multisite cohort study
Journal of the American Geriatrics Society, 2015Co-Authors: Meredith Dougherty, Joan M Teno, Pamela Harris, Amy M Corcoran, Cindy Douglas, Jackie Nelson, Deborah Way, Joan E Harrold, David CasarettAbstract:Objectives To compare residents of Assisted Living facilities receiving hospice with people receiving hospice care at home. Design Electronic health record–based retrospective cohort study. Setting Nonprofit hospices in the Coalition of Hospices Organized to Investigate Comparative Effectiveness network. Participants Individuals admitted to hospice between January 1, 2008, and May 15, 2012 (N = 85,581; 7,451 (8.7%) Assisted Living Facility, 78,130 (91.3%) home). Measurements Hospice length of stay, use of opioids for pain, and site of death. Results The Assisted Living population was more likely than the home hospice population to have a diagnosis of dementia (23.5% vs 4.7%; odds ratio (OR) = 13.3, 95% confidence interval (CI) = 12.3–14.4; P < .001) and enroll in hospice closer to death (median length of stay 24 vs 29 days). Assisted Living residents were less likely to receive opioids for pain (18.1% vs 39.7%; OR = 0.33, 95% CI = 0.29–0.39, P < .001) and less likely to die in an inpatient hospice unit (9.3% vs 16.1%; OR = 0.53, 95% CI = 0.49–0.58, P < .001) or a hospital (1.3% vs 7.6%; OR = 0.16, 95% CI = 0.13–0.19, P < .001). Conclusion Three are several differences between residents of Assisted Living receiving hospice care and individuals Living at home receiving hospice care. A better understanding of these differences could allow hospices to develop guidelines for better coordination of end-of-life care for the Assisted Living population.
Meredith Dougherty - One of the best experts on this subject based on the ideXlab platform.
-
hospice care in Assisted Living facilities versus at home results of a multisite cohort study
Journal of the American Geriatrics Society, 2015Co-Authors: Meredith Dougherty, Joan M Teno, Pamela Harris, Amy M Corcoran, Cindy Douglas, Jackie Nelson, Deborah Way, Joan E Harrold, David CasarettAbstract:Objectives To compare residents of Assisted Living facilities receiving hospice with people receiving hospice care at home. Design Electronic health record–based retrospective cohort study. Setting Nonprofit hospices in the Coalition of Hospices Organized to Investigate Comparative Effectiveness network. Participants Individuals admitted to hospice between January 1, 2008, and May 15, 2012 (N = 85,581; 7,451 (8.7%) Assisted Living Facility, 78,130 (91.3%) home). Measurements Hospice length of stay, use of opioids for pain, and site of death. Results The Assisted Living population was more likely than the home hospice population to have a diagnosis of dementia (23.5% vs 4.7%; odds ratio (OR) = 13.3, 95% confidence interval (CI) = 12.3–14.4; P < .001) and enroll in hospice closer to death (median length of stay 24 vs 29 days). Assisted Living residents were less likely to receive opioids for pain (18.1% vs 39.7%; OR = 0.33, 95% CI = 0.29–0.39, P < .001) and less likely to die in an inpatient hospice unit (9.3% vs 16.1%; OR = 0.53, 95% CI = 0.49–0.58, P < .001) or a hospital (1.3% vs 7.6%; OR = 0.16, 95% CI = 0.13–0.19, P < .001). Conclusion Three are several differences between residents of Assisted Living receiving hospice care and individuals Living at home receiving hospice care. A better understanding of these differences could allow hospices to develop guidelines for better coordination of end-of-life care for the Assisted Living population.
